Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Shares Repurchased (2016 - 2026)

Pharma-Bio Serv's Shares Repurchased history spans 13 years, with the latest figure at $1681.0 for Q1 2026.

  • For Q1 2026, Shares Repurchased changed N/A year-over-year to $1681.0; the TTM value through Jan 2026 reached $33124.0, up 713.86%, while the annual FY2025 figure was $31443.0, 179.17% up from the prior year.
  • Shares Repurchased reached $1681.0 in Q1 2026 per PBSV's latest filing, down from $9202.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $55159.0 in Q1 2022 to a low of $792.0 in Q4 2023.
  • Average Shares Repurchased over 5 years is $11480.2, with a median of $6138.0 recorded in 2023.
  • Peak YoY movement for Shares Repurchased: plummeted 91.84% in 2024, then soared 642.01% in 2025.
  • A 5-year view of Shares Repurchased shows it stood at $2379.0 in 2022, then crashed by 66.71% to $792.0 in 2023, then surged by 120.58% to $1747.0 in 2024, then soared by 426.73% to $9202.0 in 2025, then crashed by 81.73% to $1681.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Shares Repurchased are $1681.0 (Q1 2026), $9202.0 (Q4 2025), and $5004.0 (Q3 2025).